These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33363189)

  • 1. MR Imaging of Peripheral Nerves Using Targeted Application of Contrast Agents: An Experimental Proof-of-Concept Study.
    Tereshenko V; Pashkunova-Martic I; Manzano-Szalai K; Friske J; Bergmeister KD; Festin C; Aman M; Hruby LA; Klepetko J; Theiner S; Klose MHM; Keppler B; Helbich TH; Aszmann OC
    Front Med (Lausanne); 2020; 7():613138. PubMed ID: 33363189
    [No Abstract]   [Full Text] [Related]  

  • 2. Modified amino-dextrans as carriers of Gd-chelates for retrograde transport and visualization of peripheral nerves by magnetic resonance imaging (MRI).
    Pashkunova-Martic I; Manzano-Szalai K; Friske J; Aszmann O; Theiner S; Klose MHM; Baurecht D; Trattnig S; Keppler BK; Helbich TH
    J Inorg Biochem; 2021 Sep; 222():111495. PubMed ID: 34098348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium DTPA Enhancement Characteristics of the Rat Sciatic Nerve after Crush Injury at 4.7T.
    Hill BJ; Padgett KR; Kalra V; Marcillo A; Bowen B; Pattany P; Dietrich D; Quencer R
    AJNR Am J Neuroradiol; 2018 Jan; 39(1):177-183. PubMed ID: 29097415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.
    Cheng JJ; Zhu J; Liu XS; He DN; Xu JR; Wu LM; Zhou J; Feng Q
    Acta Radiol; 2012 Oct; 53(8):900-7. PubMed ID: 22919051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
    Sato T; Ito K; Tamada T; Kanki A; Watanabe S; Nishimura H; Tanimoto D; Higashi H; Yamamoto A
    Magn Reson Imaging; 2013 Oct; 31(8):1412-7. PubMed ID: 23643157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
    Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
    J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gd-DTPA T1 relaxivity in brain tissue obtained by convection-enhanced delivery, magnetic resonance imaging and emission spectroscopy.
    Haar PJ; Broaddus WC; Chen ZJ; Fatouros PP; Gillies GT; Corwin FD
    Phys Med Biol; 2010 Jun; 55(12):3451-65. PubMed ID: 20508321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer.
    Khantasup K; Saiviroonporn P; Jarussophon S; Chantima W; Dharakul T
    MAGMA; 2018 Oct; 31(5):633-644. PubMed ID: 29737435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast enhancement of the brain by folate-conjugated gadolinium-diethylenetriaminepentaacetic acid-human serum albumin nanoparticles by magnetic resonance imaging.
    Korkusuz H; Ulbrich K; Bihrer V; Welzel K; Chernikov V; Knobloch T; Petersen S; Huebner F; Ackermann H; Gelperina S; Korkusuz Y; Kromen W; Hammerstingl R; Haupenthal J; Fiehler J; Zeuzem S; Kreuter J; Vogl TJ; Piiper A
    Mol Imaging; 2012; 11(4):272-9. PubMed ID: 22954143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and in vivo evaluation of a self-assembled gadolinium(III)-iron(II) contrast agent with high relaxivity.
    Parac-Vogt TN; Vander Elst L; Kimpe K; Laurent S; Burtéa C; Chen F; Van Deun R; Ni Y; Muller RN; Binnemans K
    Contrast Media Mol Imaging; 2006; 1(6):267-78. PubMed ID: 17191767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximizing the relaxivity of Gd-complex by synergistic effect of HSA and carboxylfullerene.
    Zhen M; Zheng J; Ye L; Li S; Jin C; Li K; Qiu D; Han H; Shu C; Yang Y; Wang C
    ACS Appl Mater Interfaces; 2012 Jul; 4(7):3724-9. PubMed ID: 22704586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of two new gadolinium chelates as contrast agents for MRI.
    Wiegers CB; Welch MJ; Sharp TL; Brown JJ; Perman WH; Sun Y; Motekaitis RJ; Martell AE
    Magn Reson Imaging; 1992; 10(6):903-11. PubMed ID: 1461088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
    Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
    Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synthesis of a D-glucosamine contrast agent, Gd-DTPA-DG, and its application in cancer molecular imaging with MRI.
    Zhang W; Chen Y; Guo DJ; Huang ZW; Cai L; He L
    Eur J Radiol; 2011 Sep; 79(3):369-74. PubMed ID: 21106316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the MR Imaging Sensitivity of Upconversion Nanoparticles by an Internal and External Incorporation of the Gd(3+) Strategy for in Vivo Tumor-Targeted Imaging.
    Du H; Yu J; Guo D; Yang W; Wang J; Zhang B
    Langmuir; 2016 Feb; 32(4):1155-65. PubMed ID: 26740341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gd (III) complex conjugate of low-molecular-weight chitosan as a contrast agent for magnetic resonance/fluorescence dual-modal imaging.
    Huang Y; Boamah PO; Gong J; Zhang Q; Hua M; Ye Y
    Carbohydr Polym; 2016 Jun; 143():288-95. PubMed ID: 27083371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent.
    Chen Z; Yu D; Wang S; Zhang N; Ma C; Lu Z
    Nanoscale Res Lett; 2009 Mar; 4(7):618-26. PubMed ID: 20596430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI contrast agent for targeting glioma: interleukin-13 labeled liposome encapsulating gadolinium-DTPA.
    Liu X; Madhankumar AB; Miller PA; Duck KA; Hafenstein S; Rizk E; Slagle-Webb B; Sheehan JM; Connor JR; Yang QX
    Neuro Oncol; 2016 May; 18(5):691-9. PubMed ID: 26519740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo studies of Gd-DTPA-monoclonal antibody and gd-porphyrins: potential magnetic resonance imaging contrast agents for melanoma.
    Shahbazi-Gahrouei D; Williams M; Rizvi S; Allen BJ
    J Magn Reson Imaging; 2001 Aug; 14(2):169-74. PubMed ID: 11477676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.